POLICY PERSPECTIVE As a patient advocacy organization committed to improving the lives of all transplant recipients, Global Liver Institute (GLI) appreciates the continued leadership of medical...
(Washington, D.C., Friday, June 11, 2021)—Global Liver Institute’s International NASH Day 2021 attracted broad support beginning to approach the scale of the advanced form of fatty liver...
(Washington. D.C., Thursday, June 10, 2021)—Global Liver Institute (GLI), the worldwide leader in liver health advocacy, is pleased to announce a partnership with NutriStyle Inc. to...
WASHINGTON, D.C.—Global Liver Institute (GLI) is convening the fourth International NASH Day on June 10, 2021, at 2 a.m. Eastern, United States. Eight virtual panels of international experts will...
(Washington, D.C., Thursday, May 27, 2021)—Global Liver Institute (GLI) today formally announced its Liver Action Network, a national U.S. initiative to connect liver patients, caregivers, and...
WASHINGTON, D.C.—Global Liver Institute (GLI) will convene the fourth International NASH Day on June 10, 2021. Eight virtual panels of international experts will shed light on nonalcoholic...
As COVID-19 vaccines roll out, more and more schools and workplaces are inching toward fully reopening for in-person work or instruction. While the mental health challenges of being disconnected...
Global Liver Institute CEO Praises U.S. House Subcommittee, Organ Procurement Organization Action to Help Transplant Patients (Washington, D.C., Tuesday, May 4, 2021)—Donna Cryer, president and CEO...
(Washington, D.C., Friday, April 30, 2021)—Two witnesses from Global Liver Institute (GLI) will testify at a key U.S. House of Representatives subcommittee hearing on the need to...
POLICY PERSPECTIVE After a year spent combating the COVID-19 health crisis, the United States and the international community continue to face new issues related to the virus. This is no more...
Recent News
After elections, a lame-duck Congress will need to pass appropriations bills and hopefully “clear the decks” by passing long-awaited health reforms Members of Congress will return to Washington, DC, after the elections. Hopes remain for a productive November...
Uniting for Equity in Liver Cancer Care This month at GLI, we're excited to spotlight our Liver Cancer Program Director, Sarah Manes, as she dives into topics on advocacy, prevalence rates, risks, symptoms, treatment and survivorship for those affected with liver...
Innovation Sparks New Ideas at NORD’s Breakthrough Summit Collaborative Voices across Rare Disorders Represented during the FDA Innovation Hub Global Liver Institute’s (GLI) Program Director of Pediatric and Rare Liver Diseases, Kristin Hatcher,...
Screening for MASLD is Cost-Effective for PatientsEmerging research continues to shape our understanding of liver health, from cost-effective screening for high-risk MASLD patients to alarming rates of steatosis among young adults without a prior history of fatty...
Terri’s StoryWhen my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the pain, discomfort and fatigue from gallstones led me to an elective...
